Suppr超能文献

大肠杆菌喹诺酮耐药位点nfxD是编码拓扑异构酶IV一个亚基的parE基因的突变等位基因。

Quinolone resistance locus nfxD of Escherichia coli is a mutant allele of the parE gene encoding a subunit of topoisomerase IV.

作者信息

Breines D M, Ouabdesselam S, Ng E Y, Tankovic J, Shah S, Soussy C J, Hooper D C

机构信息

Infectious Disease Unit, Massachusetts General Hospital, Boston 02114-2696, USA.

出版信息

Antimicrob Agents Chemother. 1997 Jan;41(1):175-9. doi: 10.1128/AAC.41.1.175.

Abstract

The locus nfxD, which contributes to high-level quinolone resistance in Escherichia coli KF111b (gyrAr nfxB nfxD), is only expressed in the presence of a gyrA mutation, and maps to the region of the parC and parE genes, was outcrossed into strain KF130, creating strain DH161 (gyrAr nfxD). DNA sequence analysis of DH161 revealed no changes in the topoisomerase IV parC quinolone resistance-determining region but did identify a single T-to-A mutation in parE at codon 445, leading to a change from Leu to His. Full-length cloned parE+ partially complemented the resistance phenotype in KF111b and DH161, but did not complement the resistance phenotype in strain KF130 (gyrAr). No complementation was seen with cloned, truncated parE+. To confirm these findings, gyrAr was first outcrossed from KF130 into E. coli W3110parE10 [parE temperature sensitive(Ts)] and KL16. The transduced strains KL16 and W3110parE10 were subsequently transformed with plasmids containing cloned parE from DH161 or KL16. Cloned parE from DH161 increased norfloxacin resistance in the parE(Ts) background twofold at 30 degrees C and fourfold at 42 degrees C compared to those for cloned parE from KL16. The same experiment with a non-Ts background revealed a twofold increase in the norfloxacin MIC at both 30 and 42 degrees C. These data identify the nfxD conditional resistance locus as a mutant allele of parE. This report is the first of a quinolone-resistant parE mutant and confirms the role of topoisomerase IV as a secondary target of norfloxacin in E. coli.

摘要

nfxD位点有助于大肠杆菌KF111b(gyrAr nfxB nfxD)产生高水平喹诺酮耐药性,该位点仅在gyrA发生突变时表达,定位于parC和parE基因区域,将其导入菌株KF130,构建出菌株DH161(gyrAr nfxD)。对DH161进行DNA序列分析,结果显示拓扑异构酶IV的parC喹诺酮耐药决定区没有变化,但在parE的第445位密码子处确实发现了一个从T到A的单碱基突变,导致亮氨酸变为组氨酸。全长克隆的parE +部分互补了KF111b和DH161中的耐药表型,但不能互补菌株KF130(gyrAr)中的耐药表型。克隆的截短parE +未出现互补作用。为证实这些发现,首先将gyrAr从KF130导入大肠杆菌W3110parE10 [parE温度敏感型(Ts)]和KL16。随后用含有来自DH161或KL16的克隆parE的质粒转化转导菌株KL16和W3110parE10。与来自KL16的克隆parE相比,来自DH161的克隆parE在30℃时使parE(Ts)背景下的诺氟沙星耐药性增加两倍,在42℃时增加四倍。在非Ts背景下进行的相同实验显示,在30℃和42℃时诺氟沙星MIC均增加两倍。这些数据确定nfxD条件性耐药位点为parE的突变等位基因。本报告首次报道了喹诺酮耐药性parE突变体,并证实了拓扑异构酶IV作为诺氟沙星在大肠杆菌中的次要靶点的作用。

相似文献

引用本文的文献

9
Mechanisms of drug resistance: quinolone resistance.耐药机制:喹诺酮耐药性
Ann N Y Acad Sci. 2015 Sep;1354(1):12-31. doi: 10.1111/nyas.12830. Epub 2015 Jul 17.

本文引用的文献

7
Structure and mechanism of DNA topoisomerase II.DNA拓扑异构酶II的结构与机制。
Nature. 1996 Jan 18;379(6562):225-32. doi: 10.1038/379225a0.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验